Lesofat Gears Up for a Lesofat Health and Fitness Academy

Rocky Batara
0
Lesofat, a popular anti-obesity brand in the Philippines is all geared up in it’s 2014 Campaign to promote health and wellness, launches the Lesofat Academy.

The Lesofat Academy is an innovative program where top doctors involved in the treatment of Diabetes will be invited to act as Coaches and Preceptors to the Lesofat Field Force.  Doctors from all over the Philippines will be convening at the Midas Hotel and Casino for the first part of this event.

MD speakers will include Dr. Mia Fojas, to present Orlistat as a novel and effective agent that can prevent and treat obesity; Dr. Bien Matawaran, will share insights on Orlistat as a novel and effective agent that can prevent Cardiovascular Diseases and Dr. Gloanne Adolor will discuss on Orlistat as a novel and effective agent that can prevent Prediabetes and improve blood glucose among type 2 Diabetics.



A grandiose Fellowship Dinner will follow where Lesofat will be introducing their latest endorser, radio jock “Chikki Boom-Boom” of M.O.R.  101.9 (ABS-CBN FM Radio).

LESOFAT, marketed by InnoGen Pharmaceuticals, Inc.  is an anti-obesity drug. Its action is to prevent your body from absorbing some of the fat from the food you eat. When taken 3 times per day with meals, LESOFAT blocks about 1/3 of the fat you eat from being absorbed. Instead, this fat passes through your intestines and is excreted in your stool. When you absorb less fat, you take in fewer calories, which cause weight loss.

LESOFAT is significantly more affordable in terms of daily treatment cost, which offers savings and better patient compliance towards successful weight loss.

LESOFAT is available in 60 and 120mg capsules, at all Mercury Drug, Watsons, South Star Drug and leading drug stores nationwide. To see more of LESOFAT updates and events, check out  http://www.orlistat-lesofat.com/.  - The Lifestyle Portal

Follow Us on Twitter: @rockenroll_04
Follow Us on Instagram: @rockenroll_04

Post a Comment

0Comments

Post a Comment (0)